Alliance for Multispecialty Research, LLC.
New Orleans, Louisiana 70119
0 studies enrolling now · 14 studies all time
What they study most
Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Diseases, Chikungunya Virus, Chronic Kidney Disease, Chronic Kidney Disease (CKD), Contraception, Elevated Lp(a), Hypertension, Influenza, Human, Migraine, Obesity, Overweight
Studies at this site
- Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension — Running, not enrolling
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
- A Study About Modified RNA Vaccines Against Influenza in Healthy Adults — Completed
- A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults — Completed
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone — Completed
- A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
- A Study of Cytisinicline for Smoking Cessation in Adult Smokers — Completed
- Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers — Completed
- Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive — Stopped early
- A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
- A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
- A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) — Completed
- Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age — Completed